Several states have joined President Donald Trump's deportation efforts and are taking federal reporting requirements to immigration authorities a step further—by using their public health agencies as arms of enforcement.

A University of Mississippi study reveals that young women aged 16 to 24 across the nation do not necessarily have the needed knowledge when it comes to birth control.

The U.S. Food and Drug Administration has approved a label expansion for Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with (gMG). The expanded approval was granted to argenx.

Cardiovascular disease (CVD) remains one of Europe's biggest health challenges, according to new data from the European Society of Cardiology (ESC) Atlas of Cardiology, published in the European Heart Journal.

The U.S. Food and Drug Administration's decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw that the drug had prolonged the lives of a third of the participants in a clinical trial.

Creatine, one of the most popular supplements among gym-goers and athletes, does not appear to have the anti-inflammatory effect that many imagine. This conclusion comes from a systematic review and meta-analysis conducted in Brazil by researchers at São Paulo State University (UNESP), which evaluated clinical trials in humans. The study indicates that, to date, there is no consistent evidence that creatine reduces inflammatory markers in the body.

Inflammatory bowel diseases occur when the delicate balance between the gut, the immune system, and the microbiota is disrupted. Until now, however, it was unclear whether harmful microbes or defects in the body's own immune cells were the primary cause of these diseases.

The intravenous infusion of mesenchymal stem cells from family donors is safe and improves symptoms such as pruritus (itching), sleep disturbances, and fatigue associated with Recessive Dystrophic Epidermolysis Bullosa (RDEB), popularly known as "butterfly skin." This is one of the primary conclusions of a clinical trial conducted by researchers from the Universidad Carlos III de Madrid (UC3M), the Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) of the Ministry of Science, Innovation and Universities, the Fundación Jiménez Díaz Health Research Institute (IIS-FJD), the CIBER Rare Diseases (CIBERER), and the La Paz University Hospital in Madrid.

For decades, ultrasound has been associated with diagnostics—a routine scan in a hospital room, a monitor displaying organs, tissues, or the first image of a baby. However, researchers are now looking at ultrasound from an entirely different perspective.

Final results from a landmark EORTC randomized trial with more than 20 years of follow-up show that irradiation of the internal mammary and medial supraclavicular lymph nodes reduces breast cancer mortality but does not improve overall survival. The findings highlight the importance of very long-term follow-up when evaluating cancer treatments, particularly in patients with an otherwise favorable prognosis.